The ORR in the subset of 34 NSCLC patients with EGFR mutant was observed to be 61.8% (CR: 15, PR: 6), while in the subgroup of 42 NSCLC patients with EGFR WT, the ORR was 40.5% (CR: 7, PR: 10). Here, EGFR is linked to non-small cell lung carcinoma.